companies

InCurA

Founded 2022
Employees 10+
Primary contact
Cairo
Egypt
⁦+20 122 905 0709
Links
https://incura-med.com/
Sections

InCurA is developing a pipeline of hemostatic agents for bleeding control, covering all kinds of dental and surgical operations and also suitable for accidents and the military. The company's offering includes Starch hemostatic powder - CurASeal, and Gelatine and Collagen hemostatic sponges - ColiSorB. These products are now licensed for manufacturing in Saudi Arabia.

Founded 2022
Employees 10+
Primary contact
Cairo
Egypt
⁦+20 122 905 0709
Links
https://incura-med.com/
Sections

Funding 💰

Select investors GCCaccelerator, Tiye Angels, Kaust Innovation Ventures, UI Investments, Pharos Holding, AUC Angels, TAQADAM

Key people 🧑‍🤝‍🧑

Highlights ⭐

Content in this section is available for DHArab Premium Members only. We manually enter this information so you can save time researching different companies.

Existing users 👉 click here to login

Looking to become a member? 👉 click here for more information

Awards & Recognitions 🏆

  • 2022 ID&E Disruptors Award for the MENA region: Winner 🔗

Quotes 💬

“
We are thrilled to announce our first investment in InCurA. The company has a talented team, holds intellectual property rights for its products, has established licensing and manufacturing partnerships, and has a clear vision for addressing a critical need in the medical devices market. We are confident in InCurA's potential growth and the positive impact it will have on the Egyptian and regional economies.
— Christine Sedky, Tiye Angels Network Manager
Last update: March 31, 2024